Showing results (51-60 of 3,207) with videos related to

Sort By:
Pageof 321
Experimental & Molecular Medicine|June 14, 2022
Flow goes forward and cells step backward: endothelial migrationHeon-Woo Lee, Jae Hun Shin, Michael Simons
Experimental & Molecular Medicine|December 14, 2020
Histone acylation marks respond to metabolic perturbations and enable cellular adaptationChanhee Jo, Seokjae Park, Sungjoon Oh, et al.
Experimental & Molecular Medicine|June 2, 2021
Necroptosis molecular mechanisms: Recent findings regarding novel necroptosis regulatorsJinho Seo, Young Woo Nam, Seongmi Kim, et al.
Experimental & Molecular Medicine|May 29, 2021
Aurora kinase A, a synthetic lethal target for precision cancer medicinePui Kei Mou, Eun Ju Yang, Changxiang Shi, et al.
Experimental & Molecular Medicine|June 17, 2017
Coupling killing to neutralization: combined therapy with ceftriaxone/Pep19-2.5 counteracts sepsis in rabbitsSergio Bárcena-Varela, Guillermo Martínez-de-Tejada, Lukas Martin, et al.
Experimental & Molecular Medicine|June 17, 2017
Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseasesGuohua Lou, Zhi Chen, Min Zheng, et al.
Experimental & Molecular Medicine|June 24, 2017
Effects of chronic alcohol exposure on ischemia-reperfusion-induced acute kidney injury in mice: the role of β-arrestin 2 and glycogen synthase kinase 3Lihua Wang, Yifei Zhu, Lili Wang, et al.
Experimental & Molecular Medicine|May 27, 2017
Roles of intestinal epithelial cells in the maintenance of gut homeostasisRyu Okumura, Kiyoshi Takeda
Experimental & Molecular Medicine|June 13, 2017
Upregulation of mitochondrial NAD+ levels impairs the clonogenicity of SSEA1+ glioblastoma tumor-initiating cellsMyung Jin Son, Jae-Sung Ryu, Jae Yun Kim, et al.
Experimental & Molecular Medicine|October 26, 2021
REDD1 is a determinant of low-dose metronomic doxorubicin-elicited endothelial cell dysfunction through downregulation of VEGFR-2/3 expressionMinsik Park, Joohwan Kim, Taesam Kim, et al.
Pageof 321